Monoclonal antibody therapy in foodborne disease infections: A promising approach
Monoclonal antibody therapy for bacterial diseases involves the use of laboratory-engineered antibodies to target specific bacterial pathogens. These antibodies work by neutralising the bacteria, preventing their ability to infect host cells or produce toxins. This approach offers a promising avenue for treating bacterial infections, particularly those with antibiotic-resistant strains, by providing a targeted and potentially more effective treatment option.
